التفاصيل البيبلوغرافية
| العنوان: |
A novel stratification framework for predicting outcome in patients with prostate cancer. |
| المؤلفون: |
Luca, Bogdan-Alexandru, Moulton, Vincent, Ellis, Christopher, Edwards, Dylan R., Campbell, Colin, Cooper, Rosalin A., Clark, Jeremy, Brewer, Daniel S., Cooper, Colin S. |
| المصدر: |
British Journal of Cancer; May2020, Vol. 122 Issue 10, p1467-1476, 10p, 3 Charts, 4 Graphs |
| مصطلحات موضوعية: |
RESEARCH, RESEARCH methodology, PROGNOSIS, EVALUATION research, MEDICAL cooperation, RISK assessment, COMPARATIVE studies, GENE expression profiling, KAPLAN-Meier estimator, GENES, GENOMICS, PROSTATE-specific antigen, PROSTATE tumors, PROPORTIONAL hazards models, STATISTICS |
| مستخلص: |
Background: Unsupervised learning methods, such as Hierarchical Cluster Analysis, are commonly used for the analysis of genomic platform data. Unfortunately, such approaches ignore the well-documented heterogeneous composition of prostate cancer samples. Our aim is to use more sophisticated analytical approaches to deconvolute the structure of prostate cancer transcriptome data, providing novel clinically actionable information for this disease.Methods: We apply an unsupervised model called Latent Process Decomposition (LPD), which can handle heterogeneity within individual cancer samples, to genome-wide expression data from eight prostate cancer clinical series, including 1,785 malignant samples with the clinical endpoints of PSA failure and metastasis.Results: We show that PSA failure is correlated with the level of an expression signature called DESNT (HR = 1.52, 95% CI = [1.36, 1.7], P = 9.0 × 10-14, Cox model), and that patients with a majority DESNT signature have an increased metastatic risk (X2 test, P = 0.0017, and P = 0.0019). In addition, we develop a stratification framework that incorporates DESNT and identifies three novel molecular subtypes of prostate cancer.Conclusions: These results highlight the importance of using more complex approaches for the analysis of genomic data, may assist drug targeting, and have allowed the construction of a nomogram combining DESNT with other clinical factors for use in clinical management. [ABSTRACT FROM AUTHOR] |
|
Copyright of British Journal of Cancer is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder